Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Net Profit Margin
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Gilead Sciences Inc., net profit margin, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


The financial data reflects several notable trends in profitability, sales, and net profit margin over the observed periods.

Net Income (Loss)

Net income demonstrates considerable variability, marked by a significant loss in 2006 of approximately -$1.19 billion, followed by recovery and growth through 2014, where it peaks at over $18 billion. After 2014, net income experiences a downward trend with some fluctuations, including notable declines in 2016 and a sharp drop to nearly break-even levels in 2020. The data from 2021 onward shows intermittent recovery and decline, with income peaking again in 2023 before contracting in 2024.

Product Sales

Product sales exhibit a consistent upward trajectory over the entire period, starting at $1.8 billion in 2005 and progressively increasing to more than $28.6 billion by 2024. This growth is particularly pronounced between 2008 and 2015, followed by a relative plateau and modest increase in subsequent years. Despite changes in net income, sales maintain a generally positive growth trend.

Net Profit Margin

The net profit margin reflects significant volatility. Initial values around 45% in 2005 drop sharply to negative territory in 2006, aligning with the net loss observed in that year. Subsequently, net margins stabilize and reach a peak of over 56% in 2014. Post-2014, the margin declines considerably, showing fluctuating but lower values, with a notable near-zero margin in 2020 coinciding with the minimal net income that year. The most recent years show some recovery but margins remain substantially below earlier peaks, dropping again to a low 1.68% in 2024.

Overall, the data reveals a period of rapid expansion in sales and profitability up to the mid-2010s, followed by a phase of contraction and variability in net income and margin despite maintained product sales. This could indicate rising costs, changes in market conditions, or strategic shifts impacting profitability.


Comparison to Competitors

Gilead Sciences Inc., net profit margin, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Gilead Sciences Inc., net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)